Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials

Coleman, R; Powles, T; Paterson, A; Gnant, M; Anderson, S; Diel, I; Gralow, J; Von Minckwitz, G; Moebus, V; Bergh, J; Pritchard, K. I; Bliss, J; Cameron, D; Evans, V; Pan, H; Peto, R; Bradley, R; Gray, R; Boccardo, Francesco; Rubagotti, Alessandra

doi:10.1016/S0140-6736(15)60908-4

Bisphosphonates have profound effects on bone physiology, and could modify the process of metastasis. We undertook collaborative meta-analyses to clarify the risks and benefits of adjuvant bisphosphonate treatment in breast cancer.

Risorse UNIGE

Titolo:	Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
Autori:	Coleman, R Powles, T Paterson, A Gnant, M Anderson, S Diel, I Gralow, J Von Minckwitz, G Moebus, V Bergh, J Pritchard, K. I Bliss, J Cameron, D Evans, V Pan, H Peto, R Bradley, R Gray, R BOCCARDO, FRANCESCO RUBAGOTTI, ALESSANDRA mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2015
Rivista:	THE LANCET
Abstract:	Bisphosphonates have profound effects on bone physiology, and could modify the process of metastasis. We undertook collaborative meta-analyses to clarify the risks and benefits of adjuvant bisphosphonate treatment in breast cancer.
Handle:	http://hdl.handle.net/11567/818681
Appare nelle tipologie:	01.01 - Articolo su rivista

File in questo prodotto:

File	Descrizione	Tipologia
1-s2.0-S0140673615609084-main.pdf		Documento in versione editoriale	Open Access Visualizza/Apri

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11567/818681

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

CINECA IRIS Institutional Research Information System

File in questo prodotto: